Biohaven (BHVN) Assets (2021 - 2026)
Biohaven (BHVN) posted Assets of $466.4 million for Q1 2026, up 3.31% sequentially from $451.4 million in Q4 2025, and up 1.63% YoY from $458.9 million in Q1 2025.
Biohaven (BHVN) Assets (2021 - 2026) Analysis & Trends
Biohaven has reported Assets for 6 years, with the latest figure at $466.4 million in Q1 2026.
- Quarterly Assets rose 1.63% year-over-year to $466.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $466.4 million (up 1.63% YoY) and the FY2025 annual result came in at $451.4 million, down 26.61% from the prior year.
- Assets improved to $466.4 million in Q1 2026 per BHVN's latest filing, from $451.4 million in the prior quarter.
- Over five years, Assets peaked at $661.8 million in Q4 2022 and troughed at $135.6 million in Q3 2022.
- A 5-year average of $485.5 million and a median of $506.7 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2024: Assets jumped 365.84% in 2022, then tumbled 32.33% in 2024.
- Over 5 years, Assets stood at $661.8 million in 2022, then fell by 22.45% to $513.2 million in 2023, then climbed by 19.85% to $615.1 million in 2024, then decreased by 26.61% to $451.4 million in 2025, then gained by 3.31% to $466.4 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $466.4 million, $451.4 million, and $409.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | 370.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 370.74 Mn |
| Mar 31, 2026 | 466.41 Mn |
| Dec 31, 2025 | 451.45 Mn |
| Sep 30, 2025 | 409.12 Mn |
| Jun 30, 2025 | 550.42 Mn |
| Mar 31, 2025 | 458.95 Mn |
| Dec 31, 2024 | 615.11 Mn |
| Sep 30, 2024 | 510.52 Mn |
| Jun 30, 2024 | 582.64 Mn |
| Mar 31, 2024 | 418.53 Mn |
| Dec 31, 2023 | 513.21 Mn |
| Sep 30, 2023 | 382.74 Mn |
| Jun 30, 2023 | 506.74 Mn |
| Mar 31, 2023 | 618.52 Mn |
| Dec 31, 2022 | 661.78 Mn |
| Sep 30, 2022 | 135.65 Mn |
| Dec 31, 2021 | 142.06 Mn |